tirzepatide hfpef trial SUMMIT: a 'Huge Win' for Patients With Obesity ποΈ Rounds Table β Infographics
Description
Gua prctica con recomendaciones nutricionales basadas en evidencia para optimizar su tratamiento con medicamentos GLP-1.
Book an appointment!
Mohan, Chairman of Dr
Gs in King of Prussia
Purpose of Review This review will summarize the most contemporary trials for glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2-i) and present guidance on management and recommendations on adjunctive tapering of insulin in patients with insulin-dependent diabetes mellitus, which we term de-insulinization. Recent Findings GLP1-RA and SGLT2-i are the principal classes of diabetes medications evidencing cardiovascular benefit
We cover GLP-1 contraindications, eating disorder and GI cautions, pregnancy considerations, and screening..
